Unsurpassed 14 day accuracy1 for adults and children with diabetes and optional, real-time glucose alarms,† with readings every minute.
The FreeStyle Libre 14 day system demonstrated a reduction in hypoglycemic events4,5 and resource utilization,2,3 key drivers in diabetes costs.
Many patients require intensive insulin therapy (MDI or CSII) to achieve optimal control, putting these patients at high risk for hypoglycemia and severe hypoglycemia.§
0.55% average reduction in HbA1c16
(at 2-4 months; 95% CI, −0.70% to −0.39%)
41% reduction in number of hypoglycemic events for T1DM4
(<55 mg/dL; −0.38/24-h day; P<0.0001)
44% reduction in number of hypoglycemic events for T2DM5
(<55 mg/dL; −0.12/24-h day; P=0.0017)
* Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail Pharmacy and DME.
† Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.
ǂ Includes ambulance visits, ED visits, and hospitalizations (29.3% rate of ambulance attendance per severe hypoglycemic event8; $214.47 per ambulance attendance, updated to $232 per medical care CPI9; 17% rate of ED visit per severe hypoglycemic event10; $1387 per ED visit and $17564 per hospitalization, updated to $1645 and $20840 per medical care CPI, respectively.11)
§ Severe hypoglycemic events are defined by events requiring external help, or leading to coma or convulsion.
|| Based on a comparison of list prices of the FreeStyle Libre 14 day system versus competitors' CGM systems. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
¶ 2020 ADA recommendation for patients self-monitoring blood glucose (SMBG) on multiple-dose insulin or insulin pump therapy.
# Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
References: 1. FreeStyle Libre 2 User’s Manual. 2. Fokkert M, et al. BMJ Open Diab Res Care. 2019;7(1):e000809. doi:10.1136/ bmjdrc-2019-000809 3. Charleer S, et al. Diabetes Care. 2020;43(2):389-397. 4. Bolinder J, et al. Lancet. 2016;388(10057):2254-2263. 5. Haak T, et al. Diabetes Ther. 2017;8(1):55-73. 6. American Diabetes Association. Diabetes Care. 2018;41(5):918–928. doi:10.2337/dci18-0007 7. DCCT Research Group. N Engl J Med. 1993;329(14):977-986. 8. Heller SR, et al. [published online July 16, 2015]. Diabet Med. 2016;33(4):471-477. 9. Foos V, et al. J Med Econ. 2015;18(6):420-432. 10. Bullano MF, et al. Am J Health Syst Pharm. 2006;63(24):2473-2482. 11. Quilliam BJ, et al. Am J Manag Care. 2011;17(10):673-680. 12. Danne T, et al. Diabetes Care. 2017;40(12):1631-1640. 13. Lang J, et al. Diabetes.2019;68(suppl 1):972-P. doi:10.2337/db19-972-P 14. American Diabetes Association. Diabetes Care 2020 Jan;43(suppl 1):S77-S88. 15. Data on file. Abbott Diabetes Care. 16. Evans M, et al. [published online October 31, 2019]. Diabetes Ther. 2020;11:83-95. doi:10.1007/s13300-019-00720-0
ADC-17128 v3.0 08/20
Indications and Important Safety Information
FreeStyle Libre 14 day system: The FreeStyle Libre 14 day Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device indicated for the management of diabetes in persons age 18 and older. It is designed to replace blood glucose testing for diabetes treatment decisions. The System detects trends and tracks patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. Interpretation of the System readings should be based on the glucose trends and several sequential readings over time. The System is intended for single patient use and requires a prescription.
CONTRAINDICATIONS: Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.
WARNINGS/LIMITATIONS: Do not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. The FreeStyle Libre 14 day system does not have alarms unless the sensor is scanned, and the system contains small parts that may be dangerous if swallowed. The FreeStyle Libre 14 day system is not approved for pregnant women, persons on dialysis, or critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one. Review all product information before use or contact Abbott Toll Free (855-632-8658) or visit www.freestylelibre.us for detailed indications for use and safety information. For full indications for use and safety information, see more here.
FreeStyle Libre 2 system: The FreeStyle Libre 2 Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device with real time alarms capability indicated for the management of diabetes in persons age 4 and older.*
WARNINGS/LIMITATIONS*: The System must not be used with automated insulin dosing (AID) systems, including closed loop and insulin suspend systems. Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment. Do not take high doses of vitamin C (more than 500 mg per day), as this may falsely raise your Sensor readings. Failure to use the System according to the instructions for use may result in missing a severe low blood glucose or high blood glucose event and/or making a treatment decision that may result in injury. If glucose alarms and readings from the System do not match symptoms or expectations, use a fingerstick blood glucose value to make diabetes treatment decisions. Seek medical attention when appropriate and contact Abbott Toll Free (855-632-8658) or visit * www.freestylelibre.us for detailed indications for use and safety information.
* Please refer to www.freestylelibre.us for the indications and important safety information.
The shape of the circle sensor unit, FreeStyle, Libre, and related brand marks are owned by Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company. Product images are for illustrative purposes only.
ADC-25347 v2.0 09/20